This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Konishi, J. Articles by Dang, T. P. Search for Related Content PubMed PubMed Citation Articles by Konishi, J. Articles by Dang, T. P.

-Secretase Inhibitor Prevents Notch3 Activation and Reduces Proliferation in Human Lung Cancers

¹ Division of Hematology and Medical Oncology and ² Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee; and ³ Department of Surgery II, Nagoya City University Medical School, Nagoya, Japan

Requests for reprints: Thao P. Dang, Vanderbilt-Ingram Cancer Center, 658 PRB, Nashville, TN 37232. Phone: 615-936-3942; Fax: 615-936-1601; E-mail: thao.p.dang{at}vanderbilt.edu.

Notch receptors are key regulators of development by controlling cell-fate determination in many multicellular organisms. Genes that are important for normal differentiation play a role in cancer when their normal functions became dysregulated. Notch signaling has been shown to promote and maintain survival of many types of cancers, and we previously have shown that Notch3 plays an important role in lung cancer. In this study, we showed that a high percentage of lung cancer lines expressed Jagged1, Notch receptors, and their transcriptional target genes (HES1, Hey1), suggesting that the Notch pathway plays an important role in lung cancer biology. Thus, inhibition of Notch receptor activation represents a compelling treatment strategy. Notch activation requires proteolytic cleavage of the receptor by -secretase protein complex. In this study, we determined the ability of MRK-003, a -secretase inhibitor, to inhibit Notch3 signaling, growth, and apoptosis of lung cancer cell lines in vitro and in vivo using mouse xenograft models. We also found that MRK-003 inhibited Notch3 signaling, reduced tumor cell proliferation, inhibited serum independence, and induced apoptosis. This drug had no effect when Notch3 expression was knocked down using small interfering RNA (siRNA), suggesting that the observed effects were mediated by specific action on this receptor. In conclusion, these results support the hypothesis that inhibition of Notch activation using a -secretase inhibitor represents a potential new approach for the targeted therapy of lung cancer. [Cancer Res 2007;67(17):8051–7]

This article has been cited by other articles:

				M. Monticone, E. Biollo, A. Fabiano, M. Fabbi, A. Daga, F. Romeo, M. Maffei, A. Melotti, W. Giaretti, G. Corte, et al. z-Leucinyl-Leucinyl-Norleucinal Induces Apoptosis of Human Glioblastoma Tumor-Initiating Cells by Proteasome Inhibition and Mitotic Arrest Response Mol. Cancer Res., November 1, 2009; 7(11): 1822 - 1834. [Abstract] [Full Text] [PDF]

				K. Choi, Y.-H. Ahn, D. L. Gibbons, H. T. Tran, C. J. Creighton, L. Girard, J. D. Minna, F. X.-F. Qin, and J. M. Kurie Distinct Biological Roles for the Notch Ligands Jagged-1 and Jagged-2 J. Biol. Chem., June 26, 2009; 284(26): 17766 - 17774. [Abstract] [Full Text] [PDF]

				H. Meng, X. Zhang, K. D. Hankenson, and M. M. Wang Thrombospondin 2 Potentiates Notch3/Jagged1 Signaling J. Biol. Chem., March 20, 2009; 284(12): 7866 - 7874. [Abstract] [Full Text] [PDF]

				P.-N. Tsao, F. Chen, K. I. Izvolsky, J. Walker, M. A. Kukuruzinska, J. Lu, and W. V. Cardoso {gamma}-Secretase Activation of Notch Signaling Regulates the Balance of Proximal and Distal Fates in Progenitor Cells of the Developing Lung J. Biol. Chem., October 24, 2008; 283(43): 29532 - 29544. [Abstract] [Full Text] [PDF]

				L. Sang, H. A. Coller, and J. M. Roberts Control of the Reversibility of Cellular Quiescence by the Transcriptional Repressor HES1 Science, August 22, 2008; 321(5892): 1095 - 1100. [Abstract] [Full Text] [PDF]

				T. Wakabayashi and B. De Strooper Presenilins: Members of the {gamma}-Secretase Quartets, But Part-Time Soloists Too Physiology, August 1, 2008; 23(4): 194 - 204. [Abstract] [Full Text] [PDF]

				C. D. Peacock and D. N. Watkins Cancer Stem Cells and the Ontogeny of Lung Cancer J. Clin. Oncol., June 10, 2008; 26(17): 2883 - 2889. [Abstract] [Full Text] [PDF]